Gene · 3207
Papers1,952
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 1,952
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated computational analysis reveals HOX genes cluster as oncogenic drivers in head and neck squamous cell carcinoma. | Sci Rep | 2022 | 35562533 | PubTator, text mining | PubMed |
| Molecular signature of immunological mechanism behind impaired endometrial receptivity in polycystic ovarian syndrome. | Arch Endocrinol Metab | 2022 | 35551681 | PubTator, text mining | PubMed |
| Downregulated Reprimo by LINC00467 participates in the growth and metastasis of gastric cancer. | Bioengineered | 2022 | 35549646 | PubTator, text mining | PubMed |
| Multitranscriptome analyses of keloid fibroblasts reveal the role of the HIF-1α/HOXC6/ERK axis in keloid development. | Burns Trauma | 2022 | 35547861 | PubTator, text mining | PubMed |
| UCHL1 acts as a potential oncogene and affects sensitivity of common anti-tumor drugs in lung adenocarcinoma. | World J Surg Oncol | 2022 | 35546675 | PubTator, text mining | PubMed |
| Evolving Insights Into the Biological Function and Clinical Significance of Long Noncoding RNA in Glioblastoma. | Front Cell Dev Biol | 2022 | 35531099 | PubTator, text mining | PubMed |
| Context-specific effects of sequence elements on subcellular localization of linear and circular RNAs. | Nat Commun | 2022 | 35513423 | PubTator, text mining | PubMed |
| LINC00922 promotes deterioration of gastric cancer. | PLoS One | 2022 | 35511773 | PubTator, text mining | PubMed |
| Transcriptome analysis provides critical answers to the "variants of uncertain significance" conundrum. | Hum Mutat | 2022 | 35510381 | PubTator, text mining | PubMed |
| Anti-cancer effect of LINC00478 in bladder cancer correlates with KDM1A-dependent MMP9 demethylation. | Cell Death Discov | 2022 | 35504875 | PubTator, text mining | PubMed |
Hoxa11-mediated reduction of cell migration contributes to myeloid sarcoma formation induced by cooperation of MLL/AF10 with activating KRAS mutation in a mouse transplantation model: Hoxa11 in myeloid sarcoma formation. | Neoplasia | 2022 | 35500545 | PubTator, text mining | PubMed |
| HOXA11-AS facilitates the proliferation, cell cycle process and migration of keloid fibroblasts through sponging miR-188-5p to regulate VEGFA. | J Dermatol Sci | 2022 | 35491288 | PubTator, text mining | PubMed |
| Diagnostic workup of inherited platelet disorders. | Blood Res | 2022 | 35483920 | PubTator, text mining | PubMed |
| Genomic Variations and Immune-Related Features of TMB, PD-L1 Expression and CD8+ T Cell Infiltration in Chinese Pulmonary Sarcomatoid Carcinoma. | Int J Gen Med | 2022 | 35480996 | PubTator, text mining | PubMed |
| Targeted gene next-generation sequencing reveals genomic profile in a cohort of 46 Chinese patients with breast cancer. | J Gene Med | 2022 | 35470535 | PubTator, text mining | PubMed |
| The Landscape of lncRNAs in Multiple Myeloma: Implications in the "Hallmarks of Cancer", Clinical Perspectives and Therapeutic Opportunities. | Cancers (Basel) | 2022 | 35454868 | PubTator, text mining | PubMed |
| Suppression of MIR31HG affects the functional properties of thyroid cancer cells depending on the miR-761/MAPK1 axis. | BMC Endocr Disord | 2022 | 35443670 | PubTator, text mining | PubMed |
| Construction of a HOXA11-AS-Interact Ed Network in Keloid Fibroblasts Using Integrated Bioinformatic Analysis and in Vitro Validation. | Front Genet | 2022 | 35432479 | PubTator, text mining | PubMed |
| Comparative Transcriptome Analysis Provides Insight into Spatio-Temporal Expression Characteristics and Genetic Regulatory Network in Postnatal Developing Subcutaneous and Visceral Fat of Bama Pig. | Front Genet | 2022 | 35432468 | PubTator, text mining | PubMed |
| Decreased expression of transcription factor Homeobox A11 and its potential target genes in bladder cancer. | Pathol Res Pract | 2022 | 35430506 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3207/papers?page=22